Overview
- Product nameAnti-Slow skeletal Myosin antibodySee all Slow skeletal Myosin primary antibodies ...
- DescriptionRabbit polyclonal to Slow skeletal Myosin
- Tested applicationsWB more details
- Species reactivityReacts with: Human
Predicted to work with: Mouse, Rat - Immunogen
Synthetic peptide corresponding to a region within N terminal amino acids 35 - 84 (VEFDASKIKI EFTPEQIEEF KEAFMLFDRT PKCEMKITYG QCGDVLRALG) of Human Slow skeletal Myosin (NP_000249).
- Positive controlCOLO205 cell lysate
Properties
- FormLiquid
- Storage instructionsShipped at 4°C. Upon delivery aliquot and store at -20°C or -80°C. Avoid repeated freeze / thaw cycles.
- Storage bufferPreservative: None
Constituents: 2% Sucrose, PBS -
Concentration information loading... - PurityImmunogen affinity purified
- Clonality Polyclonal
- IsotypeIgG
- Research Areas
Applications
Our Abpromise guarantee covers the use of ab98835 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
| Application | Notes |
|---|---|
| WB | WB: Use a concentration of 1 µg/ml. Predicted molecular weight: 22 kDa. Good results were obtained when blocked with 5% non-fat dry milk in 0.05% PBS-T. |
Target
- FunctionRegulatory light chain of myosin. Does not bind calcium.
- Involvement in diseaseDefects in MYL3 are the cause of cardiomyopathy familial hypertrophic type 8 (CMH8) [MIM:608751]. Familial hypertrophic cardiomyopathy is a hereditary heart disorder characterized by ventricular hypertrophy, which is usually asymmetric and often involves the interventricular septum. The symptoms include dyspnea, syncope, collapse, palpitations, and chest pain. They can be readily provoked by exercise. The disorder has inter- and intrafamilial variability ranging from benign to malignant forms with high risk of cardiac failure and sudden cardiac death. CMH8 inheritance can be autosomal dominant or recessive.
Defects in MYL3 are the cause of cardiomyopathy familial hypertrophic with mid-left ventricular chamber type 1 (MVC1) [MIM:608751]. MVC1 is a very rare variant of familial hypertrophic cardiomyopathy, characterized by mid-left ventricular chamber thickening. - Sequence similaritiesContains 3 EF-hand domains.
- Post-translational
modificationsThe N-terminus is blocked.
N-terminus is methylated by METTL11A/NTM1. -
Database links
- Entrez Gene: 4634 Human
- Entrez Gene: 17897 Mouse
- Entrez Gene: 24585 Rat
- Omim: 160790 Human
- SwissProt: P08590 Human
- SwissProt: P09542 Mouse
- SwissProt: P16409 Rat
- Unigene: 517939 Human
- Unigene: 7353 Mouse
- Unigene: 1955 Rat
see all
Target information above from: UniProt accession
P08590
The UniProt Consortium
The Universal Protein Resource (UniProt) in 2010
Nucleic Acids Res. 38:D142-D148 (2010)
.
-
Alternative names
- Cardiac myosin light chain 1 antibodyCMH8 antibodyCMLC1 antibody
- MLC1SB antibodyMLC1V antibodyMYL3 antibodyMYL3_HUMAN antibodyMyosin light chain 1 antibodyMyosin light chain 1 slow twitch muscle B ventricular isoform antibodymyosin light chain 3 alkali ventricular skeletal slow antibodyMyosin light chain 3 antibodyslow-twitch muscle B/ventricular isoform antibodyVentricular slow twitch myosin alkali light chain antibodyVentricular/slow twitch myosin alkali light chain antibodyVLC1 antibody
see all
Anti-Slow skeletal Myosin antibody images
-
Anti-Slow skeletal Myosin antibody (ab98835) at 1 µg/ml + COLO205 cell lysate at 10 µg
Predicted band size : 22 kDa
References for Anti-Slow skeletal Myosin antibody (ab98835)
ab98835 has not yet been referenced specifically in any publications.


